Subtopic Deep Dive
Charcot-Marie-Tooth Disease Genetics
Research Guide
What is Charcot-Marie-Tooth Disease Genetics?
Charcot-Marie-Tooth disease genetics studies mutations in genes such as PMP22, MFN2, MPZ, and GJB1 that cause demyelinating and axonal neuropathies affecting Schwann cells and axons in CMT subtypes.
CMT1A from PMP22 duplication accounts for 60-70% of cases, with CMT2 from axonal genes like MFN2 and GJB1 mutations comprising 20-30% (Szigeti and Lupski, 2009, 192 citations). Genetic testing panels cover 14 genes including SH3TC2 and GDAP1, detecting mutations in 25-50% of patients (DiVincenzo et al., 2014, 187 citations). Over 17,000 patients revealed PMP22 as the top gene (DiVincenzo et al., 2014). Approximately 100 genes link to CMT subtypes.
Why It Matters
Genetic diagnosis via PMP22 and MFN2 testing guides counseling and subtype-specific therapies, as in Inherited Neuropathies Consortium data (Fridman et al., 2014, 333 citations). Panels testing 14 genes like GJB1 and MPZ yield positive rates up to 27% in clinics (DiVincenzo et al., 2014, 187 citations). Genotype-phenotype studies inform trials, with GDAP1 mutations prevalent in recessive cases (Sivera et al., 2013, 127 citations). Prevalence of 1 in 1214 drives epidemiological screening (Braathen, 2012, 125 citations).
Key Research Challenges
Genotype-Phenotype Variability
Mutations in PMP22 cause CMT1A but severity varies due to modifiers (Szigeti and Lupski, 2009). MFN2 mutations show diverse phenotypes from axonal to demyelinating (DiVincenzo et al., 2014). Identifying modifiers remains unresolved (Fridman et al., 2014).
Low Diagnostic Yield
Panels detect mutations in only 25-50% of cases despite screening 14 genes (DiVincenzo et al., 2014). Rare variants in GDAP1 and SH3TC2 contribute but escape standard tests (Sivera et al., 2013). Whole-genome sequencing is needed for unsolved cases.
De Novo Mutations Detection
De novo events in MFN2 and GJB1 explain sporadic CMT but require trio sequencing (Baets et al., 2011). Early-onset cases show high de novo rates (Baets et al., 2011, 132 citations). Validation challenges persist in low-prevalence subtypes.
Essential Papers
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
Vera Fridman, Brian N. Bundy, Mary M. Reilly et al. · 2014 · Journal of Neurology Neurosurgery & Psychiatry · 333 citations
ID number NCT01193075.
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review)
J. D. England, G. Gronseth, Gary M. Franklin et al. · 2008 · Neurology · 261 citations
1) Screening laboratory tests may be considered for all patients with polyneuropathy (Level C). Those tests that provide the highest yield of abnormality are blood glucose, serum B12 with metabolit...
Charcot–Marie–Tooth disease
Kinga Szigeti, James R. Lupski · 2009 · European Journal of Human Genetics · 192 citations
Charcot-Marie-Tooth: From Molecules to Therapy
Jonathan Morena, Anirudh Gupta, J. Chad Hoyle · 2019 · International Journal of Molecular Sciences · 190 citations
Charcot-Marie-Tooth (CMT) is the most prevalent category of inherited neuropathy. The most common inheritance pattern is autosomal dominant, though there also are X-linked and autosomal recessive s...
The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathy
Christina DiVincenzo, Christopher Elzinga, Adam C. Medeiros et al. · 2014 · Molecular Genetics & Genomic Medicine · 187 citations
Abstract We report the frequency, positive rate, and type of mutations in 14 genes ( PMP22 , GJB1 , MPZ , MFN2 , SH3TC2 , GDAP1 , NEFL , LITAF , GARS , HSPB1 , FIG4 , EGR2 , PRX , and RAB7A ) assoc...
Peripheral Neuropathy
Tae Sub Chung, Kalpana Prasad, Thomas E. Lloyd · 2013 · Neuroimaging Clinics of North America · 182 citations
Diagnosis of peripheral neuropathy
Helmar C. Lehmann, Gilbert Wunderlich, Gereon R. Fink et al. · 2020 · Neurological Research and Practice · 148 citations
Abstract Introduction Peripheral neuropathy represents a spectrum of diseases with different etiologies. The most common causes are diabetes, exposure to toxic substances including alcohol and chem...
Reading Guide
Foundational Papers
Start with Szigeti and Lupski (2009, 192 citations) for gene overview, then DiVincenzo et al. (2014, 187 citations) for 14-gene frequencies, and Fridman et al. (2014, 333 citations) for subtype burdens.
Recent Advances
Morena et al. (2019, 190 citations) on therapy targets; Lehmann et al. (2020, 148 citations) on diagnosis including genetics.
Core Methods
PMP22 duplication PCR; NGS panels for MFN2/GJB1/MPZ; trio sequencing for de novo (DiVincenzo et al., 2014; England et al., 2008).
How PapersFlow Helps You Research Charcot-Marie-Tooth Disease Genetics
Discover & Search
Research Agent uses searchPapers('Charcot-Marie-Tooth PMP22 MFN2 mutations') to find DiVincenzo et al. (2014) on 14-gene spectrum, then citationGraph to map 187 citing papers on GJB1 variants, and findSimilarPapers for genotype-phenotype studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Fridman et al. (2014) to extract subtype burdens, verifyResponse with CoVe against Szigeti and Lupski (2009) for mutation frequencies, and runPythonAnalysis to plot citation trends or gene prevalence stats with GRADE scoring for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in modifier gene research from DiVincenzo et al. (2014), flags contradictions in GDAP1 prevalence between Sivera et al. (2013) and Braathen (2012); Writing Agent uses latexEditText for genotype tables, latexSyncCitations for 10-paper bibliographies, and latexCompile for review manuscripts.
Use Cases
"Analyze mutation frequencies in 17k CMT patients and plot PMP22 vs MFN2 rates"
Research Agent → searchPapers(DiVincenzo 2014) → Analysis Agent → readPaperContent → runPythonAnalysis(pandas barplot of gene positives) → matplotlib figure of 27% PMP22 yield.
"Write LaTeX review on CMT1A genetics with citations to Lupski and Fridman"
Synthesis Agent → gap detection(Szigeti Lupski 2009) → Writing Agent → latexEditText(section on PMP22 duplication) → latexSyncCitations(Fridman 2014 et al.) → latexCompile(PDF with 333-citation table).
"Find GitHub repos analyzing CMT genetic datasets from Inherited Neuropathies Consortium"
Research Agent → searchPapers(Fridman 2014 NCT01193075) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(R code for subtype burdens, outputs CSV of patient demographics).
Automated Workflows
Deep Research workflow scans 50+ CMT papers via searchPapers and citationGraph, producing structured reports on PMP22/GJB1 mutations with GRADE grades (e.g., DiVincenzo et al., 2014). DeepScan applies 7-step CoVe to verify GDAP1 prevalence across Sivera et al. (2013) and Braathen (2012). Theorizer generates hypotheses on MFN2 modifiers from genotype-phenotype gaps in Fridman et al. (2014).
Frequently Asked Questions
What is Charcot-Marie-Tooth disease genetics?
It examines mutations in PMP22 (CMT1A), MFN2 (CMT2A), GJB1 (CMTX), MPZ causing demyelination or axonal loss (Szigeti and Lupski, 2009).
What methods detect CMT mutations?
Gene panels test 14 genes (PMP22, GJB1, MFN2 etc.) with 25-50% yield; screening starts with PMP22 duplication (DiVincenzo et al., 2014; England et al., 2008).
What are key papers?
Fridman et al. (2014, 333 citations) on subtypes; DiVincenzo et al. (2014, 187 citations) on allelic spectrum; Szigeti and Lupski (2009, 192 citations) overview.
What open problems exist?
Modifier genes for phenotype variability; <50% diagnostic yield; de novo mutations in early-onset CMT (Baets et al., 2011; Sivera et al., 2013).
Research Hereditary Neurological Disorders with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Charcot-Marie-Tooth Disease Genetics with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers
Part of the Hereditary Neurological Disorders Research Guide